Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Leafs4Lifeon Dec 13, 2018 11:09am
73 Views
Post# 29109805

RE:RE:RE:RE:Check these babies out .....

RE:RE:RE:RE:Check these babies out .....Hey Hempdoc can you show me where you read that the oversight authority will be determining regulations next week? I heard they were issuing new regulations but I haven't been able to find any information on it since November. 

Thanks in advance

Hempdoc wrote: Strizzips are out of compliance as pictured at 45 mg/strip, whereas Kinslips are actually compliant at </= to 10 mg/strip (100 mg/pkg).  However, compared to CannaStrips, Kinslips act more like an edible (slower dissolution), which means slower onset of action & slower peak effects.  There is also likely to be less homogeneity of active compound within the product, meaning less reliable dosing if one decides to consume only part of the slip.  

The proposed updated cannabis regulations (to be determined within the next week by an oversight authority) emphasizes that in order to be labeled/called a “quality product”, a producer needs to assure homogeneity or equal distribution of active compound throughout the product, meaning CannaStrips are “extremely” well positioned to succeed in this market compared with edibles & other oral/sublingual products currently being sold.


Bullboard Posts